Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent
NCT03263260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2504
Last updated 2024-09-04
Summary
Post-marketing, prospective, multicentric, non-randomized registry to evaluate the safety and efficacy of Inspiron Sirolimus Eluting Coronary Stent at the treatment of "real-world" patients.
Conditions
Interventions
- DEVICE
-
implant
coronary stent implantation
Sponsors & Collaborators
-
Scitech Produtos Medicos Ltda
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-02
- Primary Completion
- 2022-12-15
- Completion
- 2024-01-21
Countries
- Brazil
Study Locations
More Related Trials
-
DESTINY TRIAL (Inspiron x Biomatrix)
NCT01856088 ·Status: COMPLETED ·Phase: PHASE4
-
BIOFLOW-SV All Comers Registry
NCT03600948 ·Status: TERMINATED
-
BIOFLOW-SV Portugal Registry
NCT03600961 ·Status: TERMINATED
-
Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry
NCT00989066 ·Status: COMPLETED
-
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
NCT01093391 ·Status: COMPLETED ·Phase: PHASE3
-
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
NCT00231257 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
NCT06086496 ·Status: ENROLLING_BY_INVITATION
-
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon
NCT03242096 ·Status: COMPLETED ·Phase: NA
-
Sirolimus-Eluting Stents for Chronic Total Coronary Occlusions
NCT00258596 ·Status: COMPLETED ·Phase: PHASE3
-
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
NCT01426139 ·Status: COMPLETED ·Phase: NA
-
BIOFLOW-III Canada Satellite Registry
NCT01880242 ·Status: COMPLETED
-
Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent
NCT02568462 ·Status: UNKNOWN ·Phase: PHASE2
-
Multicenter Postmarket Surveillance Registry Evaluating Performance and Long Term Safety of the Presillion Stent
NCT00968019 ·Status: COMPLETED
-
OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure
NCT06919562 ·Status: RECRUITING
-
BIOFLOW III Satellite-ELADIS Orsiro Stent System
NCT02029092 ·Status: COMPLETED
-
The Direct III Post Market Study
NCT02693158 ·Status: COMPLETED
-
Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study
NCT01925027 ·Status: UNKNOWN ·Phase: PHASE4
-
BIOFLOW-III Israel Satellite Registry
NCT01895712 ·Status: COMPLETED
-
Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions
NCT00936780 ·Status: TERMINATED ·Phase: PHASE4
-
Coroflex ISAR 2000 Registry
NCT02629575 ·Status: COMPLETED
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT04175626 ·Status: COMPLETED
-
Vascular Implant Safety and Efficacy Study
NCT03263858 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
NCT02389946 ·Status: COMPLETED ·Phase: NA
-
Advapro Coronary Stent System in Coronary Artery Diseased Patients.
NCT06300268 ·Status: NOT_YET_RECRUITING ·Phase: NA